PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31060409-0	2020	Development of transferrin-bearing vesicles encapsulating aspirin for cancer therapy.	Aspirin	58-65	transferrin	Homo sapiens	15-26	
31060409-4	2020	In this work, we demonstrated that aspirin could be formulated in transferrin-bearing vesicles and that this tumor-targeted formulation could lead to an increase in the anti-proliferative efficacy of the drug in three cancer cell lines in vitro.	Aspirin	35-42	transferrin	Homo sapiens	66-77	
31060409-5	2020	The in vitro therapeutic efficacy of aspirin was significantly improved when formulated in transferrin-bearing vesicles, by about 2-fold compared to that of drug solution.	Aspirin	37-44	transferrin	Homo sapiens	91-102